KPTI - Karyopharm Therapeutics misses by $0.11 misses on revenue February, 28 2019 07:02 AM Karyopharm Therapeutics Inc. Karyopharm Therapeutics (NASDAQ:KPTI): Q4 GAAP EPS of -$0.96 misses by $0.11. More news on: Karyopharm Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, Read more ...